Skip to main content

Biomarkers

0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Aim 1 Meal Challenge 1N/A1 trial
Active Trials
NCT05621863Recruiting280Est. Aug 2026
Precision BioSciences
1 program
Chilean Gastric Cancer Task Force (FORCE 1)N/A1 trial
Active Trials
NCT03158571Completed116Est. Jan 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Human BioSciencesAim 1 Meal Challenge 1
Precision BioSciencesChilean Gastric Cancer Task Force (FORCE 1)

Clinical Trials (2)

Total enrollment: 396 patients across 2 trials

NCT05621863Human BioSciencesAim 1 Meal Challenge 1

Fruit and Vegetable Biomarker Discovery

Start: Apr 2023Est. completion: Aug 2026280 patients
N/ARecruiting
NCT03158571Precision BioSciencesChilean Gastric Cancer Task Force (FORCE 1)

Chilean Gastric Cancer Task Force (FORCE 1)

Start: Jan 2017Est. completion: Jan 2019116 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 396 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.